NCT05578586View on ClinicalTrials.gov

A Pilot Study for Optimizing Meropenem Administration in the ICU

NARecruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions

Drug Effect

Interventions

DRUG

Meropenem 1000 mg

given as 6 or 3 infusions in 15 minues or 3 hours.

Trial Locations (1)

0242

RECRUITING

Oslo University Hospital, Oslo

All Listed Sponsors

lead

Oslo University Hospital

OTHER